高渗高血糖综合征并糖尿病酮症酸中毒病例分析
A Case Report Study of Hyperglycemic Hyperosmolar Syndrome Combined with Diabetic Ketoacidosis
DOI: 10.12677/ACM.2022.1291218, PDF,    科研立项经费支持
作者: 黄彩艳, 黄 莺, 徐秀惠, 冯 琨:南方医科大学坪山总医院,内分泌与代谢病科,广东 深圳
关键词: 高渗高血糖糖尿病酮症酸中毒补液Hyperosmolar Hyperglycemic Diabetic Ketoacidosis Fluid Infusion
摘要: 病史:患者男性,52岁,因“乏力、纳差3天”入院。患者于3天前无诱因出现乏力、纳差,伴上腹部阵发性隐痛,无腹泻、呕吐,入院查随机血糖达90.2 mmol/L,β-羟丁酸6.42 mmol/L,血气分析示PH值7.068,肾功能示:尿素氮42.3 mmol/L,肌酐648 μmol/L,有效血浆渗透压371.84 mOsm/L。体征:P:103次/分,R:22次/分,BP:127/87 mmHg,皮肤干燥,舟状腹。诊断:高渗高血糖综合征,糖尿病酮症酸中毒,急性肾损伤,急性心肌损伤。治疗:予大量补液、小剂量胰岛素降糖消酮治疗。转归:患者高渗及酸中毒纠正,肾功能正常,改为皮下注射胰岛素降糖治疗。
Abstract: History: A 52-year-old male patient was admitted with “fatigue and anorexia for 3 days”. Three days ago, the patient presented with fatigue and anorexia without inductance, accompanied by parox-ysmal pain in the upper abdomen, without diarrhea and vomiting. The random blood glucose was 90.2 mmol/L, β-hydroxybutyric acid was 6.42 mmol/L, blood gas analysis showed PH 7.068, and renal function showed urea nitrogen 42.3 mmol/L. Creatinine was 648 μmol/L, and the effective plasma osmolality was 371.84 mOsm/L. Signs: P: 103 beats/min, R: 22 beats/min, BP: 127/87 mmHg, dry skin, navicular abdomen. Diagnosis: hypertonic hyperglycemic syndrome, diabetic ke-toacidosis, acute kidney injury, acute myocardial injury. Treatment: A large amount of fluid re-placement and a small dose of insulin were given to reduce blood sugar and ketone. Outcome: The patient’s hyperosmolar and acidosis were corrected, renal function was normal, and hypoglycemic treatment was changed to subcutaneous insulin injection.
文章引用:黄彩艳, 黄莺, 徐秀惠, 冯琨. 高渗高血糖综合征并糖尿病酮症酸中毒病例分析[J]. 临床医学进展, 2022, 12(9): 8445-8449. https://doi.org/10.12677/ACM.2022.1291218

参考文献

[1] 陈浩珠, 钟南山, 陆再英. 内科学[M]. 第9版. 北京: 人民卫生出版社, 2019: 745-748.
[2] Bradford, A.L., Crider, C.C., Xu, X.Z., et al. (2017) Predictors of Recurrent Hospital Admission for Patients Presenting with Diabetic Ketoaci-dosis and Hyperglycemic Hyperosmolar State. Journal of Clinical Medicine Research, 9, 35-39. [Google Scholar] [CrossRef] [PubMed]
[3] Wu, X.Y., She, D.M., Wang, F., et al. (2020) Clinical Profiles, Out-comes and Risk Factors among Type 2 Diabetic Inpatients with Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Hospital-Based Analysis over a 6-Year Period. BMC Endocrine Disorders, 20, Article No. 182. [Google Scholar] [CrossRef] [PubMed]
[4] 张力, 崔晓倩, 尚云龙, 等. 糖尿病酮症酸中毒并发高血糖高渗状态致多器官障碍综合征1例报告及文献复习[J]. 吉林大学学报(医学版), 2020, 46(5): 1070-1073.
[5] 李萍, 孔媛, 梁琳琅. 高血糖高渗状态和糖尿病酮症酸中毒合并横纹肌溶解综合征1例[J]. 内科急危重症杂志, 2019, 25(3): 261-264.
[6] 康静, 石雪, 陈琰, 等. 糖尿病高渗性昏迷合并酮症酸中毒致多器官功能障碍综合征及下丘脑综合征1例[J]. 中国现代医学杂志, 2019, 29(7): 125-126.
[7] Kusumoto, K., Koriyama, N., Kojima, N., et al. (2020) Central Pontine Myelinolysis during Treatment of Hyperglycemic Hyperosmolar Syndrome: A Case Report. Clinical Diabetes and Endocrinology, 6, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[8] Dhatariya, K.K. and Vellanki, P. (2017) Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK versus USA). Current Diabetes Reports, 17, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[9] Muneer, M. and Akbar, I. (2021) Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA. In: Islam, M.S., Ed., Diabetes: From Research to Clinical Practice, Advances in Experimental Medicine and Biology, Vol. 1307, Springer, Cham, 85-114. [Google Scholar] [CrossRef] [PubMed]
[10] Adeyinka, A. and Kondamudi, N.P. (2022) Hyperosmolar Hyper-glycemic Syndrome. StatPearls Publishing, Treasure Island.